Display options
Cite
Meyer P, Notarnicola C, Meli AC, et al. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312985.
Meyer, P., Notarnicola, C., Meli, A. C., Matecki, S., Hugon, G., Salvador, J., Khalil, M., Féasson, L., Cances, C., Cottalorda, J., Desguerre, I., Cuisset, J. M., Sabouraud, P., Lacampagne, A., Chevassus, H., Rivier, F., & Carnac, G. (2021). Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312985
Meyer, Pierre, et al. "Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312985
Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985. PMID: 34884796; PMCID: PMC8657486.
Copy Download .nbib Format: NLM
Share it on

Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985.

Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.

International journal of molecular sciences

Pierre Meyer, Cécile Notarnicola, Albano C Meli, Stefan Matecki, Gérald Hugon, Jérémy Salvador, Mirna Khalil, Léonard Féasson, Claude Cances, Jérôme Cottalorda, Isabelle Desguerre, Jean-Marie Cuisset, Pascal Sabouraud, Alain Lacampagne, Hugues Chevassus, François Rivier, Gilles Carnac

Affiliations

  1. PhyMedExp, University of Montpellier, Inserm, CNRS, 34295 Montpellier, France.
  2. Reference Centre for Neuromuscular Diseases AOC, Clinical Investigation Centre, Pediatric Neurology Department, Montpellier University Hospital, 34000 Montpellier, France.
  3. Clinical Investigation Center, Montpellier University Hospital, 34000 Montpellier, France.
  4. Myology Unit, Reference Center for Neuromuscular Diseases Euro-NmD, Inter-University Laboratory of Human Movement Sciences-EA7424, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France.
  5. Reference Center for Neuromuscular Diseases AOC, Pediatric Neurology Department, Toulouse University Hospital, 3100 Toulouse, France.
  6. Pediatric Clinical Research Unit, Pediatric Multi-thematic Module CIC 1436, Toulouse Children's Hospital, 31300 Toulouse, France.
  7. Pediatric Orthopedic and Plastic Surgery Department, Montpellier University Hospital, 34295 Montpellier, France.
  8. Reference Center for Neuromuscular Diseases Paris Nord-Ile-de-France-Est, Pediatric Neurology Department, Necker Enfant Malades University Hospital, Assistance Publique des Hôpitaux de Paris Centre, Paris University, 75019 Paris, France.
  9. Reference Center for Neuromuscular Diseases Nord-Ile-de-France-Est, Pediatric Neurology Department, Lille University Hospital, 59000 Lille, France.
  10. Reference Center for Neuromuscular Diseases Nord-Ile-de-France-Est, Pediatric Neurology Department, Reims University Hospital, 51100 Reims, France.

PMID: 34884796 PMCID: PMC8657486 DOI: 10.3390/ijms222312985

Abstract

Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca

Keywords: Duchenne muscular dystrophy; endomysial fibrosis; human; myogenesis; ryanodine receptor

References

  1. Lancet. 2002 Feb 23;359(9307):687-95 - PubMed
  2. Skelet Muscle. 2012 May 28;2(1):9 - PubMed
  3. Skelet Muscle. 2020 Nov 16;10(1):32 - PubMed
  4. FASEB J. 2007 Apr;21(4):1210-26 - PubMed
  5. J Cell Biol. 2000 Dec 11;151(6):1321-36 - PubMed
  6. Neuron. 1997 Sep;19(3):723-33 - PubMed
  7. J Biol Chem. 2013 Jan 25;288(4):2103-9 - PubMed
  8. Dis Model Mech. 2009 Jul-Aug;2(7-8):374-88 - PubMed
  9. Physiol Rev. 2002 Apr;82(2):291-329 - PubMed
  10. Biochem Pharmacol. 1996 Jul 12;52(1):149-55 - PubMed
  11. Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13258-63 - PubMed
  12. Development. 2015 May 1;142(9):1572-81 - PubMed
  13. Cell Metab. 2011 Aug 3;14(2):196-207 - PubMed
  14. Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18537-42 - PubMed
  15. Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3685-3695 - PubMed
  16. BMC Mol Biol. 2009 Jul 02;10:66 - PubMed
  17. Trends Cardiovasc Med. 2000 Aug;10(6):268-72 - PubMed
  18. Biochim Biophys Acta. 1996 Feb 9;1289(1):31-40 - PubMed
  19. J Biophys Biochem Cytol. 1961 Feb;9:493-5 - PubMed
  20. Development. 2006 Aug;133(16):3107-14 - PubMed
  21. Hum Mol Genet. 2012 Aug 1;21(15):3449-60 - PubMed
  22. Nat Rev Dis Primers. 2021 Feb 18;7(1):13 - PubMed
  23. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19023-8 - PubMed
  24. Cell Mol Life Sci. 2017 May;74(10):1923-1936 - PubMed
  25. Clin Exp Pharmacol Physiol. 2017 Jan;44(1):3-12 - PubMed
  26. Nat Med. 2009 Mar;15(3):325-30 - PubMed
  27. Acta Neuropathol. 2017 Nov;134(5):749-767 - PubMed
  28. Sci Rep. 2015 Dec 10;5:17969 - PubMed
  29. Cell Calcium. 1996 May;19(5):365-74 - PubMed
  30. Science. 1990 Nov 2;250(4981):673-6 - PubMed
  31. Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165674 - PubMed
  32. Cell Calcium. 2016 Mar;59(2-3):91-7 - PubMed
  33. Development. 2016 Feb 15;143(4):658-69 - PubMed
  34. Mol Pharmacol. 1993 Dec;44(6):1192-201 - PubMed
  35. Lab Invest. 1984 Feb;50(2):197-207 - PubMed
  36. J Physiol. 2005 Jan 15;562(Pt 2):367-80 - PubMed
  37. J Neurol Sci. 1984 May;64(2):149-60 - PubMed
  38. Cell. 1987 Dec 24;51(6):919-28 - PubMed
  39. Neurology. 1984 Nov;34(11):1436-40 - PubMed
  40. FASEB J. 2018 Feb;32(2):1025-1043 - PubMed
  41. Dev Biol. 2006 Apr 1;292(1):253-64 - PubMed
  42. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1559-64 - PubMed
  43. J Cell Physiol. 2006 Aug;208(2):435-45 - PubMed
  44. Cold Spring Harb Perspect Biol. 2012 Feb 01;4(2): - PubMed
  45. Neurology. 1978 May;28(5):439-46 - PubMed
  46. Nature. 1986 Oct 16-22;323(6089):646-50 - PubMed
  47. Genet Mol Res. 2014 Feb 28;13(1):1402-11 - PubMed
  48. Biochim Biophys Acta. 2002 Nov 4;1600(1-2):38-44 - PubMed
  49. Dev Biol. 2005 Nov 15;287(2):213-24 - PubMed
  50. J Cell Biochem. 1999 Nov;76(1):118-32 - PubMed
  51. Expert Rev Mol Med. 2014 Oct 08;16:e16 - PubMed
  52. Neurology. 1984 Jan;34(1):60-5 - PubMed
  53. J Cell Biol. 1998 Jun 15;141(6):1349-56 - PubMed
  54. Can J Physiol Pharmacol. 2010 Feb;88(2):83-91 - PubMed
  55. Am J Physiol. 1999 Dec;277(6):H2458-69 - PubMed
  56. J Cell Sci. 2003 Apr 15;116(Pt 8):1589-97 - PubMed
  57. Neuropediatrics. 2001 Jun;32(3):123-9 - PubMed
  58. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3710-4 - PubMed
  59. Development. 2012 Aug;139(16):2845-56 - PubMed
  60. Nature. 1988 Oct 20;335(6192):735-8 - PubMed
  61. Mol Ther Nucleic Acids. 2019 Dec 6;18:580-589 - PubMed
  62. J Neuropathol Exp Neurol. 2009 Jul;68(7):762-73 - PubMed
  63. Nat Med. 2015 Dec;21(12):1455-63 - PubMed
  64. FEBS J. 2013 Sep;280(17):4177-86 - PubMed
  65. J Neuromuscul Dis. 2015;2(1):73-85 - PubMed
  66. Proc Nutr Soc. 2004 May;63(2):279-86 - PubMed
  67. Sci Transl Med. 2012 Dec 12;4(164):164ra160 - PubMed
  68. Int J Mol Sci. 2020 Nov 19;21(22): - PubMed
  69. Acta Myol. 2012 Dec;31(3):184-95 - PubMed
  70. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S155-61 - PubMed

Publication Types

Grant support